1. Home
  2. GHRS vs DXPE Comparison

GHRS vs DXPE Comparison

Compare GHRS & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • DXPE
  • Stock Information
  • Founded
  • GHRS 2018
  • DXPE 1908
  • Country
  • GHRS Ireland
  • DXPE United States
  • Employees
  • GHRS N/A
  • DXPE N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • DXPE Industrial Machinery/Components
  • Sector
  • GHRS Health Care
  • DXPE Industrials
  • Exchange
  • GHRS Nasdaq
  • DXPE Nasdaq
  • Market Cap
  • GHRS 868.7M
  • DXPE 795.0M
  • IPO Year
  • GHRS 2021
  • DXPE 1996
  • Fundamental
  • Price
  • GHRS $9.10
  • DXPE $80.80
  • Analyst Decision
  • GHRS Strong Buy
  • DXPE Buy
  • Analyst Count
  • GHRS 7
  • DXPE 1
  • Target Price
  • GHRS $30.86
  • DXPE $95.00
  • AVG Volume (30 Days)
  • GHRS 208.9K
  • DXPE 136.7K
  • Earning Date
  • GHRS 05-02-2025
  • DXPE 05-07-2025
  • Dividend Yield
  • GHRS N/A
  • DXPE N/A
  • EPS Growth
  • GHRS N/A
  • DXPE 8.63
  • EPS
  • GHRS N/A
  • DXPE 4.22
  • Revenue
  • GHRS N/A
  • DXPE $1,802,040,000.00
  • Revenue This Year
  • GHRS N/A
  • DXPE $12.04
  • Revenue Next Year
  • GHRS N/A
  • DXPE $3.62
  • P/E Ratio
  • GHRS N/A
  • DXPE $19.14
  • Revenue Growth
  • GHRS N/A
  • DXPE 7.35
  • 52 Week Low
  • GHRS $6.00
  • DXPE $43.25
  • 52 Week High
  • GHRS $20.50
  • DXPE $107.06
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 39.47
  • DXPE 48.27
  • Support Level
  • GHRS $8.51
  • DXPE $77.91
  • Resistance Level
  • GHRS $9.36
  • DXPE $82.97
  • Average True Range (ATR)
  • GHRS 0.79
  • DXPE 5.27
  • MACD
  • GHRS -0.11
  • DXPE 0.50
  • Stochastic Oscillator
  • GHRS 33.94
  • DXPE 72.09

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating and production services for rotating equipment, bearings and power transmissions, industrial supplies and safety products. DXP Enterprises serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Other.

Share on Social Networks: